Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological …

…, T Hauser, B Hellmich, W Koldingsnes… - Annals of the …, 2007 - ard.bmj.com
Background: The classification of antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
and polyarteritis nodosa (PAN) for epidemiology studies is confusing. The existing …

The comparative one‐year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results …

MS Heiberg, W Koldingsnes, K Mikkelsen… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To compare the 1‐year retention rates of anti–tumor necrosis factor α (anti‐TNFα)
medications in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and …

Epidemiology of vasculitis in Europe

RA Watts, SE Lane, DGI Scott, W Koldingsnes… - Annals of the …, 2001 - ard.bmj.com
Hutchinson et al concluded that prolonged heavy cigarette smoking, but not smoking itself, is
strongly associated with rheumatoid arthritis (RA), particularly in patients without a positive …

Epidemiology of Wegener's granulomatosis in northern Norway

W Koldingsnes, H Nossent - … Journal of the American College of …, 2000 - Wiley Online Library
Objective To determine if changes in the incidence, prevalence, and clinical presentation of
Wegener's granulomatosis (WG) have occurred in the stable population of northern Norway …

Predictors of survival and organ damage in Wegener's granulomatosis

W Koldingsnes, H Nossent - Rheumatology, 2002 - academic.oup.com
Objective. To determine survival, organ damage and predictors of these outcomes in a
population‐based, longitudinal cohort study of patients with Wegener's granulomatosis (WG). …

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre

E Besada, W Koldingsnes, JC Nossent - Rheumatology, 2013 - academic.oup.com
Objective. Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with
polyangiitis (GPA) for induction and maintenance of remission. Our study aims to evaluate …

Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis

…, T Uhlig, MS Heiberg, W Koldingsnes… - Annals of the …, 2010 - ard.bmj.com
Objective To examine the effectiveness and 2-year retention rates of methotrexate (MTX) in
MTX naïve patients with psoriatic arthritis (PsA). Methods Data on 430 patients with PsA …

Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth

…, BY Nordvåg, W Koldingsnes… - Arthritis & …, 2011 - Wiley Online Library
Objective To examine possible associations between chronic inflammatory arthritides and
pregnancy outcomes with separate analyses of first and subsequent births before and after …

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with …

E Besada, W Koldingsnes, JC Nossent - Rheumatology, 2014 - academic.oup.com
Objective. Rituximab (RTX) is a B cell depleting agent used to induce and maintain
remission in patients with granulomatosis with polyangiitis (GPA). As the development of …

Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.

R Omdal, SI Mellgren, W Koldingsnes… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To determine if fatigue in patients with systemic lupus erythematosus (SLE) is
associated with levels of serum cytokines, antiphospholipid antibodies (aPL), or other …